Main Street Financial Solutions, LLC
Position in GILD — Gilead Sciences, Inc.
CIK 1763350
NEWTOWN, PA
Position in GILD
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$346,929
-$63,794 QoQ
Shares Held
2,746
-6.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#1,576
of 2,266 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Derivatives in GILD
reported options exposure · as of Jun 30, 2026CallValue
$5,088
CallShares
500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Main Street Financial Solutions, LLC holds $20,618,592 across 9 Drug Manufacturers - General names. GILD ranks #9 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
24,186 | $6,142,518 | |
| 2 | LLY |
ELI LILLY & Co
|
3,290 | $3,946,125 | |
| 3 | MRK |
Merck & Co., Inc.
|
26,862 | $3,451,767 | |
| 4 | ABBV |
AbbVie Inc.
|
13,093 | $3,294,722 | |
| 5 | AMGN |
Amgen Inc
|
4,589 | $1,661,768 | |
| 6 | PFE |
Pfizer Inc
|
33,453 | $805,548 | |
| 7 | AZN |
Astrazeneca PLC
|
3,152 | $597,682 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
6,448 | $371,533 |
All Filings in GILD
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,088 | 500 | Call | Sole | 2026-08-07 | |
| 2026-06-30 | $346,929 | 2,746 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $410,723 | 2,947 | Shares | Sole | 2026-07-29 | |
| 2025-12-31 | $275,183 | 2,242 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $362,415 | 3,265 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||